How R&D Teams Create Value from On-Market Products (MedNous)

Most pharma R&D organisations are defined and measured by how well they deliver new product innovation, which is often a high risk, high return endeavour. Yet such companies almost always have a second, highly important and sometimes underappreciated role: creating value from on market products.

This article, published in MedNous, analyses the performance of these companies in the context of new product and on-market product innovation, and demonstrates that success in on-market product innovation provides companies with the profit margins to additionally invest in new product innovation.

© 2023 Evernow Publishing Ltd

Reprinted with permission from MedNous, April 2023 (

For further insights into Europe’s MidPharmas, we examine this microcosm of the global industry and analyse how these companies thrive in our latest European MidPharma Report.